Company: MHLA
Filing Date: 2025-03-26
Form Type: DEFM14A
Source: 0001104659-25-028254
Chunk: 13

Company: Maiden Holdings, Ltd.
Filing Date: 2025-03-26
Form: DEFM14A
Chunk 13
---
 to own approximately 35.2% of the issued and outstanding Bermuda NewCo common shares, in each case excluding (i) the potential contingent consideration that may become payable to the former Kestrel equityholders and (ii) the 2,237,533 Bermuda NewCo common shares that will be held by Maiden Reinsurance Ltd. (“Maiden Re”).

Q:

What conditions must be satisfied to complete the transaction?**

Consummation of the transaction is subject to certain conditions, including approval of the first merger by Maiden shareholders; the expiration or termination of the waiting period under the HSR Act; receipt of certain required regulatory approvals or non-disapprovals pursuant to insurance laws and regulations; the absence of any injunction or order restraining the transaction or the Kestrel contribution; the absence of the imposition by a governmental authority of any Burdensome Condition (as defined in the combination agreement); the declaration of effectiveness of this registration statement, pursuant to which Bermuda NewCo common shares will be issued to Maiden shareholders; the approval of listing of the Bermuda NewCo common shares on Nasdaq (subject to official notice of issuance); and other customary conditions to closing. The obligation of Maiden, on the one hand, and Kestrel and the Kestrel equityholders, on the other hand, to consummate the transaction is also conditioned on, among other things, the accuracy of the representations and warranties made by the other party as of the closing date (subject to certain “materiality” and “material adverse effect” qualifiers), the compliance by the other party in all material respects with its covenants, and other customary conditions to closing. For a more complete summary of the conditions that must be satisfied or waived prior to completion of the transaction, see “The Combination Agreement — Conditions to the Completion of the Transaction” beginning on page 130.

**Q:**

#### What constitutes a quorum?
**A:

Two or more persons present in person at the start of the special meeting and representing in person or by proxy in excess of 50% of the total Maiden shares issued and outstanding will constitute a quorum for the transaction of business at the Maiden special meeting. Shareholder abstentions and broker non-votes will be included in the number of shareholders present at the Maiden special meeting for the purpose of determining the presence of a quorum. If within 30 minutes from the time appointed for the Maiden special meeting a quorum of Maiden shares is not present, the Maiden special meeting shall stand adjourned to the same day one week